clinical trial · NCT06325566
Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain
Mesoblast, Ltd.·phase3·recruiting·n = 300
Degenerative Disc DiseaseRexlemestrocel-L + HA mixtureSaline
brief summary
The primary purpose of this study is to evaluate the efficacy of rexlemestrocel-L+HA compared to control in reducing low back pain at 12 months post-treatment and safety of a single injection of rexlemestrocel-L+HA injected into a lumbar intervertebral disc compared to control through 12 months post-treatment.
started
Jul 3, 2024
primary completion
Oct 1, 2026
completion
Oct 1, 2027
last updated
Jan 27, 2026
official title
A Prospective, Multicenter, Randomized, Double-blind, Controlled Study to Evaluate the Efficacy and Safety of a Single Injection of Rexlemestrocel-L Combined With HA in Subjects With Moderate to Severe Chronic Low Back Pain
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol